Related Experiment Video

Updated: Apr 14, 2026

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
07:54

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Published on: December 21, 2019

7.4K

Important prognostic factors for survival in patients with malignant pleural effusion

Mauro Musa Zamboni1, Cyro Teixeira da Silva2, Rodrigo Baretta3

  • 1Pulmonology and Thoracic Surgery Division, Hospital do Câncer I, Instituto Nacional de Câncer/Ministério da Saúde, Rio de Janeiro, RJ, Brazil. mauro.zamboni@gmail.com.

BMC Pulmonary Medicine
|April 19, 2015
PubMed
Abstract

Insights

The Eastern Cooperative Oncology Group Performance Status (ECOG PS) is a key predictor of survival in patients with malignant pleural effusion (MPE). This finding aids in personalizing palliative care for cancer patients with MPE.

Area of Science:

  • Oncology
  • Palliative Care
  • Medical Statistics

Background:

  • Malignant pleural effusion (MPE) presents a significant challenge in palliative care due to poor patient survival.
  • Individualized treatment approaches are crucial for managing MPE.

Purpose of the Study:

  • To identify prognostic factors influencing survival time in patients diagnosed with MPE.
  • To develop a predictive model for survival in MPE patients.

Main Methods:

  • Retrospective, descriptive, observational study design.
  • Cox regression analysis to determine significant prognostic factors for survival.
  • Survival time defined as time from pathological diagnosis to death.

Main Results:

  • 165 patients with MPE were analyzed; median survival was 5 months.
  • Univariate analysis identified ECOG PS, primary cancer site, pleural cytology, and histology as significant factors.
  • Cox regression revealed ECOG PS as the sole independent predictor of survival (HR 73.58, p<0.0001).

Conclusions:

  • ECOG PS is a highly predictive independent factor for survival in MPE patients at initial diagnosis.
  • This prognostic information can guide physicians in selecting appropriate palliative treatment strategies for MPE.

More Related Videos

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

1.0K
Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines08:01

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on: April 21, 2022

2.3K

Related Concept Videos

Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
1.2K
Pleural Effusion I: Introduction01:25

Pleural Effusion I: Introduction

Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per se but rather a symptom or indication of an underlying disease. In normal circumstances, this space contains a small amount of fluid (5 to 15 mL), a lubricant facilitating the non-frictional movement of the pleural surfaces.
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
5.9K
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
846
Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
1.5K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.3K
Pleural Disorders: Types and Brief Description01:30

Pleural Disorders: Types and Brief Description

The pleura is a vital part of the respiratory system. It's a double-layered membrane surrounding the lungs and lining the chest cavity. The two layers of the pleura are:
1.0K